Desai Desai MY MY Owens Owens A A Geske Geske JB JB Dose-blinded myosin inhibition in patients with obstructive hypertrophic cardiomyopathy referred for septal reduction therapy: outcomes through 32 weeks Dose-blinded myosin inhibition in patients with obstructive hypertrophic cardiomyopathy referred for septal reduction therapy: outcomes through 32 weeks Circulation Circulation 2023 2023 147 147 850 850 863 863 10.1161/CIRCULATIONAHA.122.062534 10.1161/CIRCULATIONAHA.122.062534 supplied-pmid 36335531? The gene discussed is MYH14; the disease is hypertrophic cardiomyopathy.